User: Guest  Login
Title:

Different levels of incomplete terminal pathway inhibition by eculizumab and the clinical response of PNH patients

Document type:
Journal Article
Author(s):
Harder, M. J.; Hochsmann, B.; Dopler, A.; Anliker, M.; Weinstock, C.; Skerra, A.; Simmet, T.; Schrezenmeier, H.; Schmidt, C. Q.
Journal title:
Front Immunol
Year:
2019
Journal volume:
10
Pages contribution:
1639
Fulltext / DOI:
doi:10.3389/fimmu.2019.01639
WWW:
https://www.ncbi.nlm.nih.gov/pubmed/31379839
Print-ISSN:
1664-3224 (Electronic) 1664-3224 (Linking)
 BibTeX